share_log

Navigating 4 Analyst Ratings For Evolent Health

Navigating 4 Analyst Ratings For Evolent Health

瀏覽 Evolent Health 的 4 個分析師評級
Benzinga ·  03/15 12:00
In the preceding three months, 4 analysts have released ratings for Evolent Health (NYSE:EVH), presenting a wide array of perspectives from bullish to bearish.
在過去的三個月中,有4位分析師發佈了Evolent Health(紐約證券交易所代碼:EVH)的評級,提出了從看漲到看跌的各種觀點。
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
下表總結了他們最近的評估,說明了過去30天不斷變化的情緒,並將其與前幾個月進行了比較。
Analysts have set 12-month price targets for Evolent Health, revealing an average target of $45.0, a high estimate of $52.00, and a low estimate of $38.00. A 1.47% drop is evident in the current average compared to the previous average price target of $45.67.
分析師已經爲Evolent Health設定了12個月的目標股價,顯示平均目標股價爲45.0美元,最高估計爲52.00美元,低估值爲38.00美元。與之前的平均目標價45.67美元相比,當前的平均價格下降了1.47%。
Interpreting Analyst Ratings: A Closer Look
解讀分析師評級:仔細觀察
The perception of Evolent Health by financial experts is...
通過分析師最近的行...
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論